Chinese Pharmaceutical Stocks Drop as Investors Take Profit -- Market Talk
Dow Jones
Oct 09
0400 GMT - Chinese pharmaceutical stocks weaken in Hong Kong, likely to due to profit-taking. Sichuan Kelun-Biotech Biopharmaceutical is down 8.1%, Simcere Pharmaceutical Group declines 3.7% and CSPC Pharmaceutical Group is 2.85% lower. "Overall it's profit-taking and possibly rotation to tech [stocks] after a massive rally year-to-date," said Jefferies' Cui Cui. China's pharmaceutical stocks have enjoyed a strong rally this year, with Sichuan Kelun rising more than 200% since the beginning of the year. CSPC's shares have nearly doubled and Simcere's shares are up 80% year to date. (tracy.qu@wsj.com)
(END) Dow Jones Newswires
October 09, 2025 00:00 ET (04:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.